Group | Patient No. | Event No. | PLT, × 10 4/µl | Outcome of MAS | |||
---|---|---|---|---|---|---|---|
Baseline Value | At Time of MAS Onset | Worst Value During MAS | At Time of Outcome | ||||
1 | 1 | 1 | 37.3 | 12.7 | 6.2 | 23.8 | Recovered |
2a | 2 | 40.6 | 23.1 | 4.1 | 40.6e | Recovered | |
3 | 3 | 21.6 | 11.9 | 11.9 | 25.1e | Recovered | |
2 | 3 | 4 | 21.6 | 8.3 | 3.3 | 29.5 | Recovered |
4 | 5 | 24.1 | 10.9 | 10.9 | 39 | Recovered | |
5 | 6 | 14.4 | 9.4 | 9.4 | 45 | Recovered | |
7 | 14.4 | 14.4 | 11.4 | 27.5 | Recovered | ||
6 | 8 | 27.7 | 39 | 3 | 32.3 | Recovered | |
7 | 9 | 76.9 | — | 18.3 | 42.6e | Recovered | |
8 | 10 | 20.1 | 10 | 10 | 29.6 | Recovered | |
9b | 11 | 40.6 | 13 | 9.6 | 26.8 | Recovered | |
10 | 12 | 13.1 | 8.5 | 3.9 | 15.5 | Recovered | |
11 | 13 | 20.1 | 17.5 | 16 | 24.9 | Recovered | |
12 | 14 | 21.2 | 14.4 | 14.4 | 26.6 | Recovered | |
13 | 15 | 69.3 | 18.2 | 0.2 | 7.1 | Not recovered | |
3 | 14 | 16 | 32.2 | 4.6d | 4.3 | 25.5 | Recovered |
15c | 17 | 31 | 14 | 3.7 | 29.1 | Improved | |
Median | 24.1 | 12.9 | 9.4 | 27.5 | |||
Range | 13.1–76.9 | 4.6–39 | 0.2–18.3 | 7.1–45 | |||
4 | 16 | 18 | 31.5 | 7.1d | 7.1 | 20.7 | Recovered |
17 | 19 | 37.6 | 26.1 | 24.8 | 36.2 | Not recovered | |
18 | 20 | 35.7 | 10.5d | 5.9 | 41e | Improved | |
19 | 21 | 12.7 | 19 | 13.4 | 15.8 | Recovered | |
20 | 22 | 25.1 | 13.9 | 12.7 | 24.2 | Recovered | |
21 | 23 | 74.9 | 14.6 | 1.7 | — | Unknown | |
22 | 24 | 25.8 | — | 2.7 | — | Recovered | |
23 | 25 | — | — | — | — | Unknown |